sPLA2 inhibitors
US6872743B2 · kind B2 · utility
11Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2001 |
| Grant date | Mar 29, 2005 |
| Priority date | — |
| Expiry date | Dec 6, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel class of tetracyclic compounds represented by the formula I wherein R1, R2, R3, R4, R5, R6, R7, A, B, C, D, E, and n are as defined is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.